ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2026
Tea tree oil action on human corneal epithelial cells biological activity.
Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeIn ophthalmology, tea tree oil is used as an anti-infective and wound-healing compound. It is also effective in combating parasitic eyelid infections. Unfortunately, it has been linked to corneal epithelial defects when it contacts the ocular surface. METHODS AND
resultsIt was shown that concentrations of TTO exceeding 0.01% may have adverse effects on corneal epithelial cells, reducing cell viability. The IC50 (MTT assay) was 0.055% and the IC50 (NR uptake assay) was 0.1%. Cell death occurred primarily through apoptosis. Flow cytometry revealed that TTO increased the release of reactive oxygen species (ROS) threefold by the tested cells at TTO concentrations of 0.01%. However, TTO reduced ROS levels in cells previously preincubated with phorbol ester (PMA). TTO concentrations below 0.01% did not affect the level of nitric oxide (NO) released by cells. TTO concentrations (up to 0.01%) increased the number of cells in the sub-G1 and triggered an 5-6% increase in the G1 and 15% decrease in the G2 phase. Moreover, these concentrations increased the level of IL-1β twofold and IL-6 2.5-fold compared to the untreated control measured by ELISA.
conclusionsWe detected that the threshold concentration of TTO that can be considered safe for human corneal epithelial cells is 0.01% in in vitro tests. Higher concentrations were toxic to corneal epithelial cells, leading to their morphological and metabolic changes.
Indexed as
Identifiers
42319430What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.